3,313
Views
12
CrossRef citations to date
0
Altmetric
Oncology

Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response

, , , , , , , , & show all
Pages 596-610 | Received 18 Jan 2021, Accepted 21 Mar 2021, Published online: 08 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinzhu Wang, Zhenyu Wang, Qi Wei, Hongyan Wang & Yongqian Shu. (2023) Anoikis-Associated Signatures Predict Prognosis and Immune Response in Bladder Cancer. Epigenomics 15:20, pages 1033-1052.
Read now

Articles from other publishers (11)

Anqi Liang, Ying Kong, Zhihong Chen, Yishu Qiu, Yanhong Wu, Xiao Zhu & Zesong Li. (2024) Advancements and applications of single-cell multi-omics techniques in cancer research: Unveiling heterogeneity and paving the way for precision therapeutics. Biochemistry and Biophysics Reports 37, pages 101589.
Crossref
Yue Lv, Zhonghao Liu, Leihong Deng, Shunyao Xia, Qingchun Mu, Bang Xiao, Youcheng Xiu & Zan Liu. (2024) Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking. Scientific Reports 14:1.
Crossref
Yi‐Ting Chen, Wei‐Ju Tu, Zong‐Han Ye, Chih‐Ching Wu, Shir‐Hwa Ueng, Kai‐Jie Yu, Chien‐Lun Chen, Pei‐Hua Peng, Jau‐Song Yu & Ying‐Hsu Chang. (2024) Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer. PROTEOMICS – Clinical Applications.
Crossref
Qasem Al-Tashi, Maliazurina B. Saad, Amgad Muneer, Rizwan Qureshi, Seyedali Mirjalili, Ajay Sheshadri, Xiuning Le, Natalie I. Vokes, Jianjun Zhang & Jia Wu. (2023) Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. International Journal of Molecular Sciences 24:9, pages 7781.
Crossref
Ji-Ming Wu, Wang-Ren Qiu, Zi Liu, Zhao-Chun Xu & Shou-Hua Zhang. (2023) Integrative approach for classifying male tumors based on DNA methylation 450K data. Mathematical Biosciences and Engineering 20:11, pages 19133-19151.
Crossref
Xi Tian, Yue Wang, Wenhao Xu, Haidan Tang, Shuxuan Zhu, Aihetaimujiang Anwaier, Wangrui Liu, Wenfeng Wang, Wenkai Zhu, Jiaqi Su, Yuanyuan Qu, Hailiang Zhang & Dingwei Ye. (2022) Special issue “The advance of solid tumor research in China”: Multi‐omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response. International Journal of Cancer 152:1, pages 66-78.
Crossref
Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata & Jeong-Hun Kang. (2022) Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. Cancers 14:21, pages 5425.
Crossref
Jia-Qi Su, Xi Tian, Wen-Hao Xu, Aihetaimujiang Anwaier, Shi-Qi Ye, Shu-Xuan Zhu, Yue Wang, Jun Gu, Guo-Hai Shi, Yuan-Yuan Qu, Hai-Liang Zhang & Ding-Wei Ye. (2022) The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma. Cancers 14:20, pages 4992.
Crossref
Wangrui Liu, Jianfeng Xiang, Xinrui Wu, Shiyin Wei, Haineng Huang, Yu Xiao, Bo Zhai & Tao Wang. (2022) Transcriptome Profiles Reveal a 12-Signature Metabolic Prediction Model and a Novel Role of Myo-Inositol Oxygenase in the Progression of Prostate Cancer. Frontiers in Oncology 12.
Crossref
Weihua Fan, Qiao Xiong, Yuqing Ge, Ting liu, Shuxiong Zeng & Jianlong Zhao. (2022) Identifying the grade of bladder cancer cells using microfluidic chips based on impedance. The Analyst 147:8, pages 1722-1729.
Crossref
Wenhao Xu, Wenkai Zhu, Xi Tian, Wangrui Liu, Yuanyuan Wu, Aihetaimujiang Anwaier, Jiaqi Su, Shiyin Wei, Yuanyuan Qu, Hailiang Zhang & Dingwei Ye. (2021) Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref